iShares Biotechnology ETF (IBB)

NasdaqGM

203.54
+1.61 (+0.80%)
Updated Aug 18, 5:10 PM ET
AI Rating
Buy
Overall Score
77
Trend
72
Momentum
80
Risk
80

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

iShares Biotechnology ETF is trading at $203.54, up 0.80% on the session. The 50 day average sits at $186.28 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 63.1, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $185.26 with resistance near $199.05, so that band frames the current range. Average daily movement is roughly $3.53, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 77 out of 100 combines a trend score of 72, momentum of 80 and a risk score of 80.

Technical indicators

RSI (14)
63.1
strong
MACD
3.521
bullish crossover
SMA 20
192.00
SMA 50
186.28
SMA 200
--
unknown
ATR (14)
3.53
avg daily range
Support
185.26
Resistance
199.05
Volume vs 20d
0.40x
below average
Volatility
19.4%
annualised
1 month
+4.62%
3 months
+15.72%

About iShares Biotechnology ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.